Back

Influence of orthostatic blood pressure changes on the effects of intensive blood pressure control in patients with type 2 diabetes

31 August 2024 (14:30 - 14:40)
Organised by: Logo
Congress Presentation Part of: Hypertension phenotypes and cardiovascular risk Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Manlin Zhao

Liverpool Centre for Cardiovascular Science, Liverpool (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Optimal blood pressure values to reduce arterial stiffness, an analysis from UK Biobank
Doctor A. Shantsila (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Clustering analysis based on clinically available data for improving risk stratification and outcome prediction of hypertension
Doctor E. Rauseo (London, GB)
Abstract Slides Video
Presentation thumbnail
Prevalence and prediction of masked uncontrolled hypertension in patients recently hospitalised for an acute coronary syndrome
Doctor H. Hellqvist (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
One-year risk of all-cause death and major cardiovascular events in patients presenting with hypertensive crisis. A report from a global federated research health network.
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Association between the cumulative excessive systolic blood pressure and left ventricular mass index
Associate Professor Y. Lee (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension phenotypes and cardiovascular risk
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Hypertension and diabetes - ADVANCE from an uncontrolled to optimal blood pressure
thumbnail
Congress Session
Hypertension phenotypes and cardiovascular risk
thumbnail
Congress Presentation
HbA1c variability and macrovascular benefits of intensive blood pressure control in patients with type 2 diabetes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources